Tracking a new lupus Treatment's Real-Life impact
NCT ID NCT07424261
Summary
This study aims to see how well a medication called anifrolumab, given as an injection under the skin, works for controlling lupus in everyday medical practice. It will follow 125 adult lupus patients for two years after they start this treatment, tracking their disease activity, quality of life, and need for other medications. The goal is to understand the long-term benefits of this treatment in a real-world setting, outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.